SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$652B
| $727.21 | $875 |
20%
upside
| Buy | 24 days ago |
|
2
Structure Therapeutics
GPCR
$1.27B
| $22.08 | $90 |
308%
upside
| Buy | 1 month ago |
|
3
Rhythm Pharmaceuticals
RYTM
$6.78B
| $102.12 | $120 |
18%
upside
| Buy | 1 month ago |
|
4
Apogee Therapeutics
APGE
$2.26B
| $37.87 | $116 |
206%
upside
| Buy | 2 months ago |
|
5
Cidara Therapeutics
CDTX
$1.6B
| $63.17 | $68 |
8%
upside
| Buy | 2 months ago |
|
6
Amylyx Pharmaceuticals
AMLX
$910M
| $10.20 | $17 |
67%
upside
| Buy | 2 months ago |
|
|
MBX
7
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $11.55 | $44 |
281%
upside
| Buy | 4 months ago |
|
8
Vaxcyte
PCVX
$4.29B
| $33.02 | $160 |
385%
upside
| Buy | 5 months ago |
|
|
MTSR
9
Metsera, Inc. Common Stock
MTSR
$3.77B
| $35.87 | $56 |
56%
upside
| Buy | 6 months ago |
|
10
Merck
MRK
$212B
| $84.71 | $122 |
44%
upside
| Buy | 7 months ago |
|